The mechanism behind this increase in postmenopausal luminal breast cancer risk may reflect an increase in the concentration of bioavailable estradiol, which results in turn from an increase in estrogen production by aromatase in adipose tissue (25,26). The gene discussed is CYP19A1; the disease is breast carcinoma.